pharma news, views and analysis

in News
Boehringer follows Sanofi with job cuts in France
December 11, 2018 Share
X
Boehringer follows Sanofi with job cuts in France
https://pharmaphorum.com/news/boehringer-follows-sanofi-with-job-cuts-in-france/
in News
AZ and CRUK team up to go all-in on CRISPR
December 10, 2018 Share
X
AZ and CRUK team up to go all-in on CRISPR
https://pharmaphorum.com/news/az-cruk-crispr/

Latest News

Moderna shares slide after record $604m US listing

RNA drug specialist Moderna smashed the record for an initial public offering (IPO) in the US on Friday,

Moderna shares slide after record $604m US listing

https://pharmaphorum.com/news/moderna-shares-slide-after-record-604m-us-listing/

Supernus says ADHD drug trounces rivals, but shares slide

Supernus Pharma has two phase III trials showing its attention-deficit hyperactivity disorder (ADHD) drug SPN-812 met its objectives,

Supernus says ADHD drug trounces rivals, but shares slide

https://pharmaphorum.com/news/supernus-says-adhd-drug-trounces-rivals-but-shares-slide/

After delayed IPO, Mereo gets US listing via OncoMed merger

UK biotech Mereo BioPharma is merging with Californian biotech OncoMed in an all-stock deal that swells its pipeline

After delayed IPO, Mereo gets US listing via OncoMed merger

https://pharmaphorum.com/news/after-delayed-ipo-mereo-gets-us-listing-via-oncomed-merger/

See all

Views & Analysis

Dutch biotech Pharming plans to challenge big pharma in rare diseases

The introduction of Shire’s preventive treatment for hereditary angioedema has shaken up the market for drugs for this

Dutch biotech Pharming plans to challenge big pharma in rare diseases

https://pharmaphorum.com/r-d/views-analysis-r-d/pharming-challenge-pharma-rare-diseases/

Four steps for more patient centric trials

Medidata’s general manager & senior vice president EMEA, Christian Hebenstreit, on placing the patient experience at the heart

Four steps for more patient centric trials

https://pharmaphorum.com/r-d/views-analysis-r-d/four-steps-patient-centric-trials/

Is the pharma gender gap starting to close?

When Emma Walmsley took the reins of GlaxoSmithKline (GSK) in 2016, becoming the first woman to head up

Is the pharma gender gap starting to close?

https://pharmaphorum.com/views-analysis-sales-marketing/is-the-pharma-gender-gap-starting-to-close/

See all

Debates & Insights

Understanding blockchain – a practical guide for life sciences companies

Within the life science industry, uptake of blockchain is in the early stages, but with investment levels in

Understanding blockchain – a practical guide for life sciences companies

https://pharmaphorum.com/digital/insights-digital/understanding-blockchain-life-sciences/

Marketing science – brand innovation for pharma

Combining fields such as economics, statistics and operations research, marketing science has for some time operated under-the-radar as

Marketing science – brand innovation for pharma

https://pharmaphorum.com/debates-insight-sales-marketing/marketing-science-brand-innovation-for-pharma/

Digital health: how can technology be used to engage hard-to-reach patients and assist with patient monitoring?

Helping someone live with a condition as complex as MS can be fraught with challenges. MS professionals are

Digital health: how can technology be used to engage hard-to-reach patients and assist with patient monitoring?

https://pharmaphorum.com/debates-insight-digital/digital-health-can-technology-used-engage-hard-reach-patients-assist-patient-monitoring/

See all

Partner Content

Predictions for 2019: Ten trends that will shape the future of drug development and commercialization

eBook Provides Biopharma Decision Makers With What’s Next Insights to Navigate Challenges and Capitalize on the Opportunities Ahead

Predictions for 2019: Ten trends that will shape the future of drug development and commercialization

https://pharmaphorum.com/partner-content/press-releases/predictions-for-2019-ten-trends-that-will-shape-the-future-of-drug-development-and-commercialisation/

SMi’s 3D Cell Culture announces key industry speakers and agenda released

SMi’s 3d Cell Culture agenda released

SMi’s 3D Cell Culture announces key industry speakers and agenda released

https://pharmaphorum.com/partner-content/smis-3d-cell-culture-announces-key-industry-speakers-and-agenda-released/

SMi’s 10th Annual RNA Therapeutics Returns this February 2019

RNA Therapeutics 2019

SMi’s 10th Annual RNA Therapeutics Returns this February 2019

https://pharmaphorum.com/events/smis-10th-annual-rna-therapeutics-returns-this-february-2019/

See all

Search

Advanced Search

Trending